BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$2.18
+0.09 (+4.31%)
As of May 10, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
197.50M
Net Income
27.79M
Gross Margin
71.5%
Profit Margin
14.1%
Rev Growth
+5.2%
D/E Ratio
9.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 197.50M 187.70M 22.38M 21.94M
Gross Profit 141.13M 134.13M 7.24M 7.09M
Operating Income 36.54M 31.25M 3.89M 4.25M
Net Income 27.79M 23.77M 3.27M 4.37M
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Rev Growth +5.2% +5.2% -5.1% +24.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 36.97M 36.97M 11.22M 12.91M
Total Equity 4.10M 4.10M 63.17M 61.05M
D/E Ratio 9.02 9.02 0.18 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 51.93M 46.89M 5.70M 5.36M
Free Cash Flow 2.62M 2.18M